Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajat Kumar

Showing results (331-340 of 341) with videos related to

Pageof 35
Sort By:
British Journal of Haematology|March 19, 2016
Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective studyRena Buckstein, Richard A Wells, Nancy Zhu, et al.
BMC Cancer|December 16, 2017
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimensJohn F Seymour, Hartmut Döhner, Aleksandra Butrym, et al.
Haematologica|February 2, 2023
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-upKyoung Ha Kim, TaeHyung Kim, Igor Novitzky-Basso, et al.
Ejhaem|September 2, 2022
The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemiaDennis D H Kim, Igor Novitzky Basso, Taehyung Simon Kim, et al.
Blood|May 20, 2015
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blastsHervé Dombret, John F Seymour, Aleksandra Butrym, et al.
British Journal of Haematology|July 6, 2017
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient-related factors and measuring from time of first red blood cell transfusion dependence: an MDS-CAN analysisHeather A Leitch, Ambica Parmar, Richard A Wells, et al.
Bone Marrow Transplantation|September 7, 2020
Setting up and sustaining blood and marrow transplant services for children in middle-income economies: an experience-driven position paper on behalf of the EBMT PDWPLawrence Faulkner, Marta Verna, Attilio Rovelli, et al.
Bone Marrow Transplantation|March 26, 2021
Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaGeorgina Daher-Reyes, TaeHyung Kim, Igor Novitzky-Basso, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 23, 2016
Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic RegionsRajat Kumar, Fumihiko Kimura, Kwang Woo Ahn, et al.
Eclinicalmedicine|January 22, 2026
HCT Frailty Scale (HCT-FS) for assessing frailty in adult candidates for allogeneic haematopoietic cell transplantation: an international prospective, observational cohort studyMaría Queralt Salas, Tommy Alfaro Moya, Ivan Pasic, et al.
Pageof 35

Showing results (331-340 of 341) with videos related to

Sort By:
Pageof 35
British Journal of Haematology|March 19, 2016
Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective studyRena Buckstein, Richard A Wells, Nancy Zhu, et al.
BMC Cancer|December 16, 2017
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimensJohn F Seymour, Hartmut Döhner, Aleksandra Butrym, et al.
Haematologica|February 2, 2023
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-upKyoung Ha Kim, TaeHyung Kim, Igor Novitzky-Basso, et al.
Ejhaem|September 2, 2022
The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemiaDennis D H Kim, Igor Novitzky Basso, Taehyung Simon Kim, et al.
Blood|May 20, 2015
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blastsHervé Dombret, John F Seymour, Aleksandra Butrym, et al.
British Journal of Haematology|July 6, 2017
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient-related factors and measuring from time of first red blood cell transfusion dependence: an MDS-CAN analysisHeather A Leitch, Ambica Parmar, Richard A Wells, et al.
Bone Marrow Transplantation|September 7, 2020
Setting up and sustaining blood and marrow transplant services for children in middle-income economies: an experience-driven position paper on behalf of the EBMT PDWPLawrence Faulkner, Marta Verna, Attilio Rovelli, et al.
Bone Marrow Transplantation|March 26, 2021
Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaGeorgina Daher-Reyes, TaeHyung Kim, Igor Novitzky-Basso, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 23, 2016
Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic RegionsRajat Kumar, Fumihiko Kimura, Kwang Woo Ahn, et al.
Eclinicalmedicine|January 22, 2026
HCT Frailty Scale (HCT-FS) for assessing frailty in adult candidates for allogeneic haematopoietic cell transplantation: an international prospective, observational cohort studyMaría Queralt Salas, Tommy Alfaro Moya, Ivan Pasic, et al.
Pageof 35